The HemOnc Pulse

Rahul Banerjee, MD
  • ٤٫٨ (٢٦)
  • العلوم
  • يتم التحديث شهريًا

Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Rahul Banerjee, MD, covering all topics in the world of hematologic oncology.

  1. قبل ٦ أيام

    Clinical Advances in Myeloma: A Nordic Perspective

    Host Rahul Banerjee, MD, speaks with Drs. Frederik Schjesvold and Frida Askeland on myeloma trial results, relevance in the IMROZ/CEPHEUS era, and advances in treating elderly, frail patients.

    ١٢ من الدقائق

  2. ٧ سبتمبر

    Grand Rounds in Leukemia: MD Anderson Fellows on AML Endpoints

    MD Anderson fellows discuss AML, MRD endpoints, and evolving trial strategies in a dynamic grand rounds–style presentation.

    ٩ من الدقائق

  3. ٢٧ أغسطس · إضافة

    Editor’s Special Episode: Progress and Prospects in CLL Management

    William Wierda, MD, PhD of the University of Texas MD Anderson discusses advances in chronic lymphocytic leukemia care, from targeted therapies and resistance to immune dysfunction and prevention with Blood Cancers Today Managing Editor, Nichole Tucker.

  4. ٢٢ أغسطس · إضافة

    Today’s Clinical Trials Define the Next Era in Myeloma

    In this Editor’s Special Episode of The HemOnc Pulse, Dr. Hira Mian of McMaster University shares expert insights on the evolving treatment landscape for multiple myeloma. From optimizing selinexor use, to understanding long-term MonumenTAL-1 data with talquetamab, to the promise of emerging trispecific antibodies, Dr. Mian highlights the biggest shifts shaping care today.

  5. ١٥ أغسطس

    ‘The HemOnc Pulse Live:’ Transforming ALL Treatment Pathways

    A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.

  6. ٨ أغسطس · إضافة

    Evolving Approaches in the Management of MDS

    Review of IMerge phase 3 data on imetelstat for lower-risk MDS and how prior therapies affect treatment outcomes, and other ASCO 2025 MDS updates with Andrew Brunner, MD.

    ٣٢ من الدقائق

  7. ١ أغسطس

    ‘The HemOnc Pulse Live!’: AML in Transition

    During a session at The HemOnc Pulse Live! moderated by Naval Daver, MD, Eunice Wang, MD presents new insights in acute myeloid leukemia care, joined by Aditi Shastri, MBBS, Tapan Kadiya, MD, and Kelly Chien, MD for a rich panel on mutation loss, minimal residual disease, and transplant timing.

  8. ٢٥ يوليو · إضافة

    From Trials to Practice: What's New and What's Next for Myeloma

    Drs. Gurbakhash Kaur and Danai Dima discuss next-gen CAR T and bispecific therapies for myeloma, including agents for extramedullary disease and GPRC5D targets.

    ٣٨ من الدقائق
مشاهدة الكل (٧٦)

التقييمات والمراجعات

٤٫٨
من ٥
‫٢٦ من التقييمات‬

حول

Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Rahul Banerjee, MD, covering all topics in the world of hematologic oncology.

المعلومات

  • صناع العمل
    Rahul Banerjee, MD
  • سنوات النشاط
    ٢٠٢٢ - ٢٠٢٥
  • الحلقات
    ٧٦
  • التقييم
    ملائم
  • حقوق النشر
    © Copyright 2025 All rights reserved.
  • موقع البرنامج على الويب
    The HemOnc Pulse

قد يعجبك أيضًا